alendronate has been researched along with Coronary Restenosis in 4 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The current treatment for coronary restenosis following balloon angioplasty involves the use of a mechanical or drug eluting stent (DES)." | 2.48 | Liposomal alendronate for the treatment of restenosis. ( Golomb, G; Gutman, D, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grad, E | 1 |
| Zolotarevsky, K | 1 |
| Danenberg, HD | 1 |
| Nordling-David, MM | 1 |
| Gutman, D | 2 |
| Golomb, G | 2 |
| Park, K | 1 |
| Banai, S | 1 |
| Finkelstein, A | 1 |
| Almagor, Y | 1 |
| Assali, A | 1 |
| Hasin, Y | 1 |
| Rosenschein, U | 1 |
| Apruzzese, P | 1 |
| Lansky, AJ | 1 |
| Kume, T | 1 |
| Edelman, ER | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intravenous Liposomal Alendronate Infusion in Subjects Undergoing Bare Metal Coronary Stent Implantation[NCT00739466] | Phase 2 | 226 participants (Actual) | Interventional | 2008-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for alendronate and Coronary Restenosis
| Article | Year |
|---|---|
Liposomal alendronate for the treatment of restenosis.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Coronary Restenosis; Humans; Liposomes; Macr | 2012 |
1 trial available for alendronate and Coronary Restenosis
| Article | Year |
|---|---|
Targeted anti-inflammatory systemic therapy for restenosis: the Biorest Liposomal Alendronate with Stenting sTudy (BLAST)-a double blind, randomized clinical trial.
Topics: Administration, Intravenous; Alendronate; Coronary Angiography; Coronary Restenosis; Dose-Response R | 2013 |
2 other studies available for alendronate and Coronary Restenosis
| Article | Year |
|---|---|
The role of monocyte subpopulations in vascular injury following partial and transient depletion.
Topics: Alendronate; Animals; Carotid Artery Injuries; Clodronic Acid; Coronary Restenosis; Liposomes; Male; | 2018 |
A new method for preventing restenosis: a single IV injection of drug-loaded nanoparticles.
Topics: Alendronate; Animals; Cell Line; Cell Survival; Clinical Trials, Phase II as Topic; Coronary Resteno | 2009 |